Click to view your profile
Click to search for condition or expert
Click to open main menu
Acquired Agranulocytosis Latest Advances
Find the Latest Research About Acquired Agranulocytosis
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/20/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
See more filters
Pegfilgrastim-Apgf (Nyvepria): Biosimilar USFDA Approval for the Treatment of Chemotherapy-induced Febrile Neutropenia and Current Updates on Clinical Trials.
Condition:
Chemotherapy-Induced Febrile Neutropenia
Journal:
Current drug targets
Treatment Used:
Pegfilgrastim-Apgf
Number of Patients:
0
Published:
April 11, 2022
VIEW PUBLICATION
Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer.
Condition:
Stage III Gastric Cancer
Journal:
BMC cancer
Treatment Used:
Adjuvant Chemotherapy with Docetaxel/Cisplatin/S-1 Followed by S-1 (DCS)
Number of Patients:
30
Published:
October 02, 2021
VIEW PUBLICATION
PAC1 Receptor Mediates Electroacupuncture-Induced Neuro and Immune Protection During Cisplatin Chemotherapy.
Condition:
Advanced Neurotoxicity or Neuropathies During Chemotherapy
Journal:
Frontiers in immunology
Treatment Used:
PAC1-Agonists/Electroacupuncture (EA)
Published:
September 23, 2021
VIEW PUBLICATION
Comparing the efficacy and side-effects of PDLASTA® (Pegfilgrastim) with PDGRASTIM® (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial.
Condition:
Breast Cancer
Journal:
BMC cancer
Treatment Used:
PDLASTA® (Pegfilgrastim) vs. PDGRASTIM® (Filgrastim)
Number of Patients:
80
Published:
April 24, 2021
VIEW PUBLICATION
Prospective Multicenter Phase II Study of Biweekly TAS-102 and Bevacizumab for Metastatic Colorectal Cancer.
Condition:
Metastatic Colorectal Cancer (mCRC)
Journal:
Anticancer research
Treatment Used:
Biweekly TAS-102 and Bevacizumab
Number of Patients:
19
Published:
April 04, 2021
VIEW PUBLICATION
Appendectomy Versus Observation for Appendicitis in Neutropenic Children With Cancer.
Condition:
Children with Cancer and Neutropenic Appendicitis (NA)
Journal:
Pediatrics
Treatment Used:
Appendectomy vs Observation
Number of Patients:
66
Published:
January 28, 2021
VIEW PUBLICATION
Is PEGylated G-CSF superior to G-CSF in patients with breast cancer receiving chemotherapy? A systematic review and meta-analysis.
Condition:
Chemotherapy-Induced Neutropenia
Journal:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Treatment Used:
PEGylated Granulocyte Colony-Stimulating Factor vs. Granulocyte Colony-Stimulating Factor
Number of Patients:
0
Published:
July 05, 2020
VIEW PUBLICATION
Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer.
Condition:
Grade 3 Neutropenia with Hormone Receptor-Positive Metastatic Breast Cancer
Journal:
Breast cancer research and treatment
Treatment Used:
Palbociclib
Number of Patients:
107
Published:
June 25, 2020
VIEW PUBLICATION
Usefulness of serum galactomannan in initiating and modifying antifungal therapy in children with cancer and persistent high-risk febrile neutropenia.
Condition:
Children with Cancer and Persistent High-Risk Febrile Neutropenia (HRFN)
Journal:
Mycoses
Treatment Used:
Antifungal Therapy (AFT)
Number of Patients:
191
Published:
April 30, 2020
VIEW PUBLICATION
A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer.
Condition:
Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer
Journal:
Annals of oncology : official journal of the European Society for Medical Oncology
Treatment Used:
Filgrastim for Primary Prophylaxis
Number of Patients:
324
Published:
April 24, 2020
VIEW PUBLICATION
Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.
Condition:
Refractory/Relapsed Acute Myeloid Leukemia
Journal:
Cancer medicine
Treatment Used:
Clofarabine, Cytarabine, and Mitoxantrone
Number of Patients:
52
Published:
March 19, 2020
VIEW PUBLICATION
Concurrent Hepatotoxicity and Neutropenia Induced by Clozapine.
Condition:
Schizophrenia
Journal:
Archives of Iranian medicine
Treatment Used:
Clozapine
Number of Patients:
1
Published:
February 16, 2020
VIEW PUBLICATION
Showing 1-12 of 46
Next
Last Updated: 01/20/2023